The relationship between adipose tissue and bone metabolism

Clinical Biochemistry

Volumn 45, Issue 12, 2012, Pages 874-879

  Gimble, Jeffrey M ^a   Nuttall, Mark E ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adipogenesis; Bone marrow mesenchymal stromal stem cells; Bone marrow microenvironment; Hematopoietic stem cells; Obesity; Osteogenesis; Osteoporosis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; GLUCOCORTICOID RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOGENESIS; ADIPOSE TISSUE; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; BONE NECROSIS; BRAIN FUNCTION; CELL LINEAGE; CORRELATION ANALYSIS; HEMATOPOIETIC STEM CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESPAN; LIPID STORAGE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADIPOSE TISSUE, WHITE; AGING; ANIMALS; BONE AND BONES; BONE MARROW CELLS; BRAIN; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; OBESITY; OSTEOPOROSIS;

EID: 84863863767     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.03.006     Document Type: Review

References (138)

1. Piney A. The anatomy of the bone marrow: with special reference to the distribution of the red marrow. Br Med J 1922, 2:792-795.
2. Friedenstein A.J., Piatetzky S., Petrakova K.V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966, 16(3):381-390.
3. Friedenstein A.J. Precursor cells of mechanocytes. Int Rev Cytol 1976, 47:327-359.
4. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3(4):393-403.
5. Caplan A.I. Mesenchymal stem cells. J Orthop Res 1991, 9(5):641-650.
6. Bianco P., Robey P.G., Saggio I., Riminucci M. "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum Gene Ther 2010, 21(9):1057-1066.
7. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007, 213(2):341-347.
8. Stenderup K., Justesen J., Eriksen E.F., Rattan S.I., Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res 2001, 16(6):1120-1129.
9. Justesen J., Stenderup K., Eriksen E.F., Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002, 71(1):36-44.
10. Kassem M., Marie P.J. Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 2011, 10(2):191-197.
11. Post S., Abdallah B.M., Bentzon J.F., Kassem M. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone 2008, 43(1):32-39.
12. Kassem M., Abdallah B.M., Saeed H. Osteoblastic cells: differentiation and trans-differentiation. Arch Biochem Biophys 2008, 473(2):183-187.
13. Taipaleenmaki H., Abdallah B.M., Aldahmash A., Saamanen A.M., Kassem M. Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. Exp Cell Res 2011, 317(6):745-756.
14. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
15. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992, 102(Pt. 2):341-351.
16. Gimble J.M., Robinson C.E., Wu X., Kelly K.A. The function of adipocytes in the bone marrow stroma: an update. Bone 1996, 19(5):421-428.
17. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J Cell Biochem 2006, 98(2):251-266.
18. Nuttall M.E., Gimble J.M. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004, 4(3):290-294.
19. Gimble J.M., Robinson C.E., Wu X., Kelly K.A., Rodriguez B.R., Kliewer S.A., et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 1996 Nov, 50(5):1087-1094.
20. Kajkenova O., Lecka-Czernik B., Gubrij I., Hauser S.P., Takahashi K., Parfitt A.M., et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res 1997 Nov, 12(11):1772-1779.
21. Lecka-Czernik B., Gubrij I., Moerman E.J., Kajkenova O., Lipschitz D.A., Manolagas S.C., et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J Cell Biochem 1999 Sep 1, 74(3):357-371.
22. Lazarenko O.P., Rzonca S.O., Hogue W.R., Swain F.L., Suva L.J., Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007.
23. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102(2):274-282.
24. Tornvig L., Mosekilde L.I., Justesen J., Falk E., Kassem M. Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int 2001, 69(1):46-50.
25. Lecka-Czernik B., Moerman E.J., Grant D.F., Lehmann J.M., Manolagas S.C., Jilka R.L. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002, 143(6):2376-2384.
26. Di Iorgi N., Mo A.O., Grimm K., Wren T.A., Dorey F., Gilsanz V. Bone acquisition in healthy young females is reciprocally related to marrow adiposity. J Clin Endocrinol Metab 2010, 95(6):2977-2982.
27. Wren T.A., Chung S.A., Dorey F.J., Bluml S., Adams G.B., Gilsanz V. Bone marrow fat is inversely related to cortical bone in young and old subjects. J Clin Endocrinol Metab 2011, 96(3):782-786.
28. Shen W., Chen J., Punyanitya M., Shapses S., Heshka S., Heymsfield S.B. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int 2007, 18(5):641-647.
29. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., et al. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 1998 Jul 13, 142(1):295-305.
30. Bowers R.R., Lane M.D. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 2007, 6(4):385-389.
31. Meunier P., Aaron J., Edouard C., Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971, 80:147-154.
32. Martin R.B., Zissimos S.L. Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 1991, 12(2):123-131.
33. Gimble J.M. The function of adipocytes in the bone marrow stroma. New Biol 1990, 2(4):304-312.
34. Custer R.P., Ahlfeldt F.E. Studies on the structure and function of bone marrow. II. Variation in cellularity in various bones with advancing years of life and relative response to stimuli. J Lab Clin Med 1932, 17:960-962.
35. Huggins C., Blocksom B.H., Noonan W.J. Temperature conditions in bone marrow of rabbit, pigeon, and albino rat. Am J Physiol 1936, 115:395-401.
36. Huggins C., Noonan W.J. An increase in reticulo-endothelial cells in outlying bone marrow consequent upon a local increase in temperature. J Exp Med 1936, 64:275-280.
37. Krings A., Rahman S., Huang S., Lu Y., Czernik P.J., Lecka-Czernik B. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone 2011.
38. Motyl K.J., Rosen C.J. Temperatures rising: brown fat and bone. Discov Med 2011, 11(58):179-185.
39. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone 2011.
40. Trayhurn P., Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005, 33(Pt. 5):1078-1081.
41. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A 2008, 105(13):5266-5270.
42. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2(1):35-43.
43. Barbour K.E., Zmuda J.M., Boudreau R., Strotmeyer E.S., Horwitz M.J., Evans R.W., et al. Adipokines and the risk of fracture in older adults. J Bone Miner Res 2011 Feb 10.
44. Allen T.D., Dexter T.M. The essential cells of the hemopoietic microenvironment. Exp Hematol 1984, 12(7):517-521.
45. Dexter T.M., Moore M.A., Sheridan A.P. Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J Exp Med 1977, 145(6):1612-1616.
46. Dexter T.M., Testa N.G. Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol 1976, 14:387-405.
47. Lanotte M., Allen T.D., Dexter T.M. Histochemical and ultrastructural characteristics of a cell line from human bone-marrow stroma. J Cell Sci 1981, 50:281-297.
48. Lanotte M., Scott D., Dexter T.M., Allen T.D. Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro. J Cell Physiol 1982, 111(2):177-186.
49. Whitlock C.A., Tidmarsh G.F., Muller-Sieburg C., Weissman I.L. Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule. Cell 1987, 48(6):1009-1021.
50. Pietrangeli C.E., Hayashi S., Kincade P.W. Stromal cell lines which support lymphocyte growth: characterization, sensitivity to radiation and responsiveness to growth factors. Eur J Immunol 1988, 18(6):863-872.
51. Kincade P.W., Lee G., Pietrangeli C.E., Hayashi S., Gimble J.M. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol 1989, 7:111-143.
52. Dorheim M.A., Sullivan M., Dandapani V., Wu X., Hudson J., Segarini P.R., et al. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol 1993 Feb, 154(2):317-328.
53. Taichman R.S., Emerson S.G. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994, 179(5):1677-1682.
54. Zhu J., Garrett R., Jung Y., Zhang Y., Kim N., Wang J., et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 2007 May 1, 109(9):3706-3712.
55. Wu J.Y., Purton L.E., Rodda S.J., Chen M., Weinstein L.S., McMahon A.P., et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways. Proc Natl Acad Sci U S A 2008 Nov 4, 105(44):16976-16981.
56. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003 Oct 23, 425(6960):841-846.
57. Kearns A.E., Khosla S., Kostenuik P.J. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 2008, 29(2):155-192.
58. Gimble J.M., Dorheim M.A., Cheng Q., Medina K., Wang C.S., Jones R., et al. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular characterization. Eur J Immunol 1990 Feb, 20(2):379-387.
59. Ookura N., Fujimori Y., Nishioka K., Kai S., Hara H., Ogawa H. Adipocyte differentiation of human marrow mesenchymal stem cells reduces the supporting capacity for hematopoietic progenitors but not for severe combined immunodeficiency repopulating cells. Int J Mol Med 2007, 19(3):387-392.
60. Belaid-Choucair Z., Lepelletier Y., Poncin G., Thiry A., Humblet C., Maachi M., et al. Human bone marrow adipocytes block granulopoiesis through neuropilin-1-induced granulocyte colony-stimulating factor inhibition. Stem Cells 2008 Jun, 26(6):1556-1564.
61. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460(7252):259-263.
62. Yokota T., Meka C.S., Kouro T., Medina K.L., Igarashi H., Takahashi M., et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 2003 Nov 15, 171(10):5091-5099.
63. Yokota T., Meka C.S., Medina K.L., Igarashi H., Comp P.C., Takahashi M., et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002 May, 109(10):1303-1310.
64. DiMascio L., Voermans C., Uqoezwa M., Duncan A., Lu D., Wu J., et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007 Mar 15, 178(6):3511-3520.
65. Mikhail A.A., Beck E.X., Shafer A., et al. Leptin stimulates fetal and adult erythroid and myeloid development. Blood 1997, 89(5):1507-1512.
66. Islam A. Do bone marrow fat cells or their precursors have a pathogenic role in idiopathic aplastic anaemia?. Med Hypotheses 1988, 25(4):209-217.
67. Takaku T., Malide D., Chen J., Calado R.T., Kajigaya S., Young N.S. Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy. Blood 2010, 116(15):e41-e55.
68. Yang H., Youm Y.H., Dixit V.D. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol 2009, 183(5):3040-3052.
69. Smith S.M., Ossa-Gomez L.J. A quantitative histologic comparison of the thymus in 100 healthy and diseased adults. Am J Clin Pathol 1981, 76(5):657-665.
70. Friedenstein A.J., Lalykina K.S. Thymus cells are inducible to osteogenesis. Eur J Immunol 1972, 2(6):602-603.
71. Krampera M., Sartoris S., Liotta F., Pasini A., Angeli R., Cosmi L., et al. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 2007 Oct, 16(5):797-810.
72. Ebihara K., Kusakabe T., Hirata M., Masuzaki H., Miyanaga F., Kobayashi N., et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 2006 Nov 21.
73. Javor E.D., Cochran E.K., Musso C., Young J.R., Depaoli A.M., Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005, 54(7):1994-2002.
74. Chu Y., Huddleston G.G., Clancy A.N., Harris R.B., Bartness T.J. Epididymal fat is necessary for spermatogenesis, but not testosterone production or copulatory behavior. Endocrinology 2010, 151(12):5669-5679.
75. Dixit V.D. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol 2008, 84(4):882-892.
76. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010 Aug 1, 185(3):1836-1845.
77. Ortega E., Xu X., Koska J., Marie Francisco A., Scalise M., Ferrante A.W., et al. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 2008 Nov 13.
78. Weisberg S.P., Mccann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808.
79. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003 Dec, 112(12):1821-1830.
80. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009 Apr 9, 360(15):1518-1525.
81. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009 Apr 9, 360(15):1509-1517.
82. Enerback S. The origins of brown adipose tissue. N Engl J Med 2009, 360(19):2021-2023.
83. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009 Apr 9, 360(15):1500-1508.
84. Nedergaard J., Bengtsson T., Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007, 293(2):E444-E452.
85. Goodpaster B.H., He J., Watkins S., Kelley D.E. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001, 86(12):5755-5761.
86. Johannsen D.L., Conley K.E., Bajpeyi S., Punyanitya M., Gallagher D., Zhang Z., et al. Ectopic lipid accumulation and reduced glucose tolerance in elderly adults are accompanied by altered skeletal muscle mitochondrial activity. J Clin Endocrinol Metab 2012 Jan, 97(1):242-250.
87. Tailleux A., Wouters K., Staels B. Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 2011.
88. Mano T., Nishimura N., Iwase S. Sympathetic neural influence on bone metabolism in microgravity (Review). Acta Physiol Hung 2010, 97(4):354-361.
89. Shi Y., Oury F., Yadav V.K., Wess J., Liu X.S., Guo X.E., et al. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab 2010 Mar 3, 11(3):231-238.
90. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000 Jan 21, 100(2):197-207.
91. Elefteriou F., Takeda S., Ebihara K., Magre J., Patano N., Kim C.A., et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 2004 Mar 2, 101(9):3258-3263.
92. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002 Nov 1, 111(3):305-317.
93. Shi Y., Yadav V.K., Suda N., Liu X.S., Guo X.E., Myers M.G., et al. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci U S A 2008 Dec 23, 105(51):20529-20533.
94. Shi H., Song C.K., Giordano A., Cinti S., Bartness T.J. Sensory or sympathetic white adipose tissue denervation differentially affects depot growth and cellularity. Am J Physiol Regul Integr Comp Physiol 2005, 288(4):R1028-R1037.
95. Bartness T.J., Shrestha Y.B., Vaughan C.H., Schwartz G.J., Song C.K. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol Cell Endocrinol 2010, 318(1-2):34-43.
96. Bartness T.J., Song C.K. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. J Lipid Res 2007, 48(8):1655-1672.
97. Kreier F., Buijs R.M. Evidence for parasympathetic innervation of white adipose tissue, clearing up some vagaries. Am J Physiol Regul Integr Comp Physiol 2007, 293(1):R548-R549. author reply R550-542, discussion R553-544.
98. Berthoud H.R., Fox E.A., Neuhuber W.L. Vagaries of adipose tissue innervation. Am J Physiol Regul Integr Comp Physiol 2006, 291(5):R1240-R1242.
99. Giordano A., Song C.K., Bowers R.R., Ehlen J.C., Frontini A., Cinti S., et al. White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol 2006 Nov, 291(5):R1243-1255.
100. Coleman D.L. A historical perspective on leptin. Nat Med 2010, 16(10):1097-1099.
101. Friedman J.M., Leibel R.L., Siegel D.S., Walsh J., Bahary N. Molecular mapping of the mouse ob mutation. Genomics 1991, 11(4):1054-1062.
102. Kajimura D., Hinoi E., Ferron M., Kode A., Riley K.J., Zhou B., et al. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J Exp Med 2011 Apr 11, 208(4):841-851.
103. Yadav V.K., Oury F., Suda N., Liu Z.W., Gao X.B., Confavreux C., et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009 Sep 4, 138(5):976-989.
104. Gimble J.M. Leptin's balancing act between bone and fat. J Bone Miner Res 2011, 26(8):1694-1697.
105. Bartell S.M., Rayalam S., Ambati S., Gaddam D.R., Hartzell D.L., Hamrick M., et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res 2011 Apr 21.
106. Hamrick M.W., Della-Fera M.A., Choi Y.H., Pennington C., Hartzell D., Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 2005, 20(6):994-1001.
107. Williams G.A., Callon K.E., Watson M., Costa J.L., Ding Y., Dickinson M., et al. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res 2011 Feb 15.
108. Hinoi E., Gao N., Jung D.Y., Yadav V., Yoshizawa T., Myers M.G., et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 2008 Dec 29, 183(7):1235-1242.
109. Clemens T.L., Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011, 26(4):677-680.
110. Gundberg C.M., Markowitz M.E., Mizruchi M., Rosen J.F. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985, 60(4):736-739.
111. Sinha M.K., Ohannesian J.P., Heiman M.L., Kriauciunas A., Stephens T.W., Magosin S., et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996 Mar 1, 97(5):1344-1347.
112. Gimble JM, Sutton, GA, Ptitsyn, AA, Floyd, ZE, Bunnell, BA: Circadian rhythms in adipose tissue: an update. Curr Opin Clin Nutr Met Care (In Press).
113. Gimble J.M., Floyd Z.E. Fat circadian biology. J Appl Physiol 2009, 107(5):1629-1637.
114. Kawai M., Rosen C.J. PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 2010, 6(11):629-636.
115. Zvonic S., Ptitsyn A.A., Conrad S.A., Scott L.K., Floyd Z.E., Kilroy G., et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes 2006 Apr, 55(4):962-970.
116. Zvonic S., Ptitsyn A.A., Kilroy G., Wu X., Conrad S.A., Scott L.K, et al. Circadian oscillation of gene expression in murine calvarial bone. J Bone Miner Res 2007, 22:357-365.
117. Shimba S., Ishii N., Ohta Y., Ohno T., Watabe Y., Hayashi M., et al. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc Natl Acad Sci U S A 2005 Aug 23, 102(34):12071-12076.
118. Kawai M., Green C.B., Lecka-Czernik B., Douris N., Gilbert M.R., Kojima S., et al. A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation. Proc Natl Acad Sci U S A 2010 Jun 8, 107(23):10508-10513.
119. Shi X., Shi W., Li Q., Song B., Wan M., Bai S., et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep 2003 Apr, 4(4):374-380.
120. Zhang W., Yang N., Shi X.M. Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem 2008, 283(8):4723-4729.
121. Lecka-Czernik B., Ackert-Bicknell C., Adamo M.L., Marmolejos V., Churchill G.A., Shockley K.R., et al. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology 2007 Feb, 148(2):903-911.
122. Rzonca S.O., Suva L.J., Gaddy D., Montague D.C., Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004, 145(1):401-406.
123. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet 2011, 377(9773):1276-1287.
124. Jones L.C., Hungerford D.S. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol 2004, 16(4):443-449.
125. Schwartz A.V., Sellmeyer D.E., Vittinghoff E., Palermo L., Lecka-Czernik B., Feingold K.R., et al. Thiazolidinedione (TZD) use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006 Apr 11.
126. Lecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep 2010, 8(4):178-184.
127. Montagnani A., Gonnelli S., Alessandri M., Nuti R. Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res 2011, 23(2):84-90.
128. Rosen C.J., Ackert-Bicknell C.L., Adamo M.L., Shultz K.L., Rubin J., Donahue L.R., et al. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 2004 Nov, 35(5):1046-1058.
129. Botolin S., Faugere M.C., Malluche H., Orth M., Meyer R., Mccabe L.R. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005, 146(8):3622-3631.
130. Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010 Jul 23, 142(2):309-319.
131. Bollag R.J., Zhong Q., Phillips P., Min L., Zhong L., Cameron R., et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 2000 Mar, 141(3):1228-1235.
132. Xie D., Cheng H., Hamrick M., Zhong Q., Ding K.H., Correa D., et al. Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 2005 Dec, 37(6):759-769.
133. Nuche-Berenguer B., Lozano D., Gutierrez-Rojas I., Moreno P., Marinoso M.L., Esbrit P., et al. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia. J Endocrinol 2011 May, 209(2):203-210.
134. Monami M., Dicembrini I., Antenore A., Mannucci E. Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: a meta-analysis of randomized clinical trials. Diabetes Care 2011, 34(11):2474-2476.
135. Duque G., Rivas D. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells. J Bone Miner Res 2007, 22(10):1603-1611.
136. Ugur-Altun B., Altun A., Gerenli M., Tugrul A. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity. Diabetes Res Clin Pract 2005, 68(3):217-222.
137. Paternoster L., Ohlsson C., Sayers A., Vandenput L., Lorentzon M., Evans D.M., et al. OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. J Clin Endocrinol Metab 2010 Aug, 95(8):3940-3948.
138. Lang P., van Harmelen V., Ryden M., Kaaman M., Parini P., Carneheim C., et al. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS One 2008, 3(3):e1713.